Click Here to Go Directly to the Story
Register/Subscribe
Home


 
 


U.S. EDITION
Full Table of Contents
Cover Story
BusinessWeek Investor -- Special Report
Up Front
Readers Report
Corrections & Clarifications
Books
Technology & You
Economic Viewpoint
Economic Trends
Business Outlook

News: Analysis & Commentary
In Business This Week
Washington Outlook
International Outlook
Information Technology
Social Issues
Energy
Developments to Watch
Finance
Sports Business

Entertainment
Working Life
Marketing
Inside Wall Street
Figures of the Week
Editorials


INTERNATIONAL EDITIONS
International -- Asian Cover Story
International -- European Cover Story
International -- Letter From Argentina
International -- Spotlight on Japan
International -- Readers Report
International -- Corrections & Clarifications
International -- Asian Business
International -- European Business
International -- Latin America
International -- Finance
International -- Int'l Figures of the Week
International -- Editorials




MAY 28, 2001

INSIDE WALL STREET

Day of the Mid-Caps

 
By Gene G. Marcial
Gene G. Marcial

  STORY TOOLS
Printer-Friendly Version
E-Mail This Story

Related Items Table: Battipaglia's Mid-Cap Picks


INSIDE WALL STREET

Day of the Mid-Caps

From Vector: A No-Nicotine Smoke

Southern Voices Answer Triton Calls

With the Fed on a mission to jump-start the economy, expect the small-to-mid-cap stocks to lead the market's next upswing. So argues Joe Battipaglia, Chairman of Investment Policy at Gruntal, who says the group performs best in an environment of declining interest rates. Each time the Fed has eased rates in years when the economy was in recession, the universe of low-cap stocks in the Russell 2000 usually outpaced the large-cap Russell 1000. So Battipaglia has overweighted his portfolio with small-and-mid-cap stocks in such areas as pharmaceuticals, financials, and technology.

Two of Battipaglia's top picks: Caliper Technologies (CALP ), both a tech and a biotech play, and North Fork Bancorp. (NFB ), a bank holding company serving New York and Connecticut.

Caliper's proprietary technology sets a new standard in biological research, says Battipaglia. It miniaturizes and integrates entire lab processes into a "lab chip" workstation that contains all the hardware and software to perform lab analyses. The technology is sold to big drugmakers to speed up research and cut its cost. Drugmakers such as Merck have acquired biotechs to help them in their quest for new drugs. He expects Caliper to be in the black in 2002, earning 21 cents a share.

North Fork's stock has been on the rise in part because of its allure as a possible target in a consolidating industry. North Fork posted solid first-quarter results as deposits and loans grew briskly. The opening of more Manhattan branches, says Battipaglia, will spur growth. First-quarter deposits at its New York branches grew at an annualized 56% for existing branches. And its pending purchase of Commercial Bank of New York, he adds, should boost growth and its value. He expects earnings of $1.92 in 2001 and $2.20 in 2002.



By Gene G. Marcial


Get BusinessWeek directly on your desktop with our RSS feeds.XML

Add BusinessWeek news to your Web site with our headline feed.

Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video.

To subscribe online to BusinessWeek magazine, please click here.

Learn more, go to the BusinessWeekOnline home page

Back to Top

MAY
TODAY'S MOST POPULAR STORIES

  1. These Men Could Kill SarbOx
  2. This Year's Holiday Hit Toy: Zhu Zhu Pets
  3. Wall Street Plays Hardball
  4. America's Best Place to Raise Your Kids
  5. Abercrombie & Fitch Bargains for a Rebound

Get Free RSS Feed >>
  MARKET INFO

Portfolio Service Update

Stock Lookup

Enter name or ticker



Media Kit | Special Sections | MarketPlace | Knowledge Centers
McGraw-Hill Cos.